While MDA-MB-468 and Cal51 exhibit similar sensitivities to AF based on their GI50 values, we found that their ability to upregulate CYP1A1 and CYP1B1 expression after AF treatment was drastically different. The gene discussed is CYP1B1; the disease is atrial fibrillation.